mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.6 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
BIRB 0796 |
FIMM |
pan-cancer |
AAC |
0.086 |
0.6 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |